The aim of this paper is to summarize the available evidence supporting the link between late onset hypogonadism (LOH) and associated common clinical illnesses, focusing on metabolic diseases. The possible benefits or risks related to testosterone replacement therapy (TRT) in these conditions will also be analyzed.

Is late-onset hypogonadotropic hypogonadism a specific age-dependent disease, or merely an epiphenomenon caused by accumulating disease-burden? / Corona, Giovanni; Maseroli, Elisa; Rastrelli, Giulia; Francomano, Davide; Aversa, Antonio; Hackett, Geoffrey I; Ferri, Simona; Sforza, Alessandra; Maggi, Mario. - In: MINERVA ENDOCRINOLOGICA. - ISSN 0391-1977. - STAMPA. - 41:(2016), pp. 196-210.

Is late-onset hypogonadotropic hypogonadism a specific age-dependent disease, or merely an epiphenomenon caused by accumulating disease-burden?

CORONA, GIOVANNI;MASEROLI, ELISA;RASTRELLI, GIULIA;MAGGI, MARIO
2016

Abstract

The aim of this paper is to summarize the available evidence supporting the link between late onset hypogonadism (LOH) and associated common clinical illnesses, focusing on metabolic diseases. The possible benefits or risks related to testosterone replacement therapy (TRT) in these conditions will also be analyzed.
2016
41
196
210
Corona, Giovanni; Maseroli, Elisa; Rastrelli, Giulia; Francomano, Davide; Aversa, Antonio; Hackett, Geoffrey I; Ferri, Simona; Sforza, Alessandra; Mag...espandi
1a - Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1058552
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 51
  • ???jsp.display-item.citation.isi??? 39
social impact